Clinical utility of thromboelastography: One size does not fit all

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 7, 2010, Pages 699-706

  Wegner, Julie ^a,b   Popovsky, Mark A ^b,c  

^a MIDWESTERN UNIVERSITY   (United States)

^b HAEMONETICS CORPORATION   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

cardiac surgery; coagulation; hemostasis; Thromboelastography

Indexed keywords

FRESH FROZEN PLASMA;

BLEEDING; BLOOD CLOT LYSIS; BLOOD CLOTTING; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; PRIORITY JOURNAL; REVIEW; THROMBOELASTOGRAPHY;

BLOOD COAGULATION DISORDERS; HEMOSTASIS; HUMANS; THROMBELASTOGRAPHY;

EID: 78049313736     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1265286     Document Type: Review

References (109)

1. Roberts H R., Monroe D M., Escobar M A. Current concepts of hemostasis: implications for therapy. Anesthesiology 2004 100 (3) 722-730
2. Monroe D M., Hoffman M. What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 2006 26 (1) 41-48
3. Gallimore M J., Harris S L., Tappenden K A., Winter M, Jones D W. Urokinase induced fibrinolysis in thromboelastography: a model for studying fibrinolysis and coagulation in whole blood. J Thromb Haemost 2005 3 (11) 2506-2513
4. Despotis G, Eby C, Lublin D M. A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery. Transfusion 2008 48 (1, Suppl) 2S-30S
5. Mann K G., Brummel-Ziedins K, Undas A, Butenas S. Does the genotype predict the phenotype? Evaluations of the hemostatic proteome. J Thromb Haemost 2004 2 (10) 1727-1734
6. Karnicki K, Owen W G., Miller R S., McBane R D. II. Factors contributing to individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol 2002 22 (9) 1495-1499
7. Vanschoonbeek K, Feijge M A., Van Kampen R J. et al. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2004 2 (3) 476-484
8. Hertfelder H J., Bös M, Weber D, Winkler K, Hanfland P, Preusse C J. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Semin Thromb Hemost 2005 31 (4) 426-440
9. Stover E P., Siegel L C., Parks R et al, Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Anesthesiology 1998 88 (2) 327-333 (Pubitemid 28081191)
10. Despotis G J., Joist J H., Goodnough L T. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997 43 (9) 1684-1696
11. Engoren M C., Habib R H., Zacharias A, Schwann T A., Riordan C J., Durham S J. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002 74 (4) 1180-1186
12. Rao S V., Jollis J G., Harrington R A. et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004 292 (13) 1555-1562
13. Spiess B D., Royston D, Levy J H. et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004 44 (8) 1143-1148
14. Ganter M T., Hofer C K. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008 106 (5) 1366-1375
15. Tripodi A, Chantarangkul V, Mannucci P M. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br J Haematol 2009 147 (1) 77-82
16. Mann K G., Butenas S, Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 2003 23 (1) 17-25
17. Essell J H., Martin T J., Salinas J, Thompson J M., Smith V C. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993 7 (4) 410-415
18. Kaufmann C R., Dwyer K M., Crews J D., Dols S J., Trask A L. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997 42 (4) 716-720 discussion 720-722
19. Kamal A H., Tefferi A, Pruthi R K. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 2007 82 (7) 864-873
20. Rooney M M., Farrell D H., van Hemel B M., de Groot P G., Lord S T. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction. Blood 1998 92 (7) 2374-2381
21. Mousa S A., Bozarth J M., Seiffert D, Feuerstein G Z. Using thrombelastography to determine the efficacy of the platelet glycoprotein IIb/IIIa antagonist, roxifiban, on platelet/fibrin-mediated clot dynamics in humans. Blood Coagul Fibrinolysis 2005 16 (3) 165-171
22. Carr M Jr.E., Carr S L. Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development. Blood Coagul Fibrinolysis 1995 6 (1) 79-86
23. Chakroun T, Gerotziafas G T., Seghatchian J, Samama M M., Hatmi M, Elalamy I. The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profile. Thromb Haemost 2006 95 (5) 822-828
24. Gottumukkala V N., Sharma S K., Philip J. Assessing platelet and fibrinogen contribution to clot strength using modified thromboelastography in pregnant women. Anesth Analg 1999 89 (6) 1453-1455
25. Goto S. Understanding the mechanism and prevention of arterial occlusive thrombus formation by anti-platelet agents. Curr Med Chem Cardiovasc Hematol Agents 2004 2 (2) 149-156 (Pubitemid 38854976)
26. Oshita K, Az-ma T, Osawa Y, Yuge O. Quantitative measurement of thromboelastography as a function of platelet count. Anesth Analg 1999 89 (2) 296-299
27. Bowbrick V A., Mikhailidis D P., Stansby G. Influence of platelet count and activity on thromboelastography parameters. Platelets 2003 14 (4) 219-224
28. Bochsen L, Wiinberg B, Kjelgaard-Hansen M, Steinbrüchel D A., Johansson P I. Evaluation of the TEG platelet mapping assay in blood donors. Thromb J 2007 5 3
29. Nielsen V G., Geary B T., Baird M S. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesth Analg 2000 91 (1) 35-39
30. Collet J P., Shuman H, Ledger R E., Lee S, Weisel J W. The elasticity of an individual fibrin fiber in a clot. Proc Natl Acad Sci U S A 2005 102 (26) 9133-9137
31. Gurbel P A., Bliden K P., Guyer K et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005 46 (10) 1820-1826
32. McCrath D J., Cerboni E, Frumento R J., Hirsh A L., Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005 100 (6) 1576-1583
33. Marchal G, Leroux M, Samama M. Atlas of Thrombodynamography. Niles, IL Haemoscope Corporation 2003
34. Avidan M S., Alcock E L., Da Fonseca J et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004 92 (2) 178-186
35. Shore-Lesserson L, Manspeizer H E., DePerio M, Francis S, Vela-Cantos F, Ergin M A. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999 88 (2) 312-319
36. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001 86 (4) 575-578
37. Ak K, Isbir C S., Tetik S et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 2009 24 (4) 404-410
38. Westbrook A J., Olsen J, Bailey M, Bates J, Scully M, Salamonsen R F. Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. Heart Lung Circ 2009 18 (4) 277-288
39. Tuman K J., Spiess B D., McCarthy R J., Ivankovich A D. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 1989 69 (1) 69-75
40. Nuttall G A., Oliver W C., Ereth M H., Santrach P J. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997 11 (7) 815-823
41. Wang J S., Lin C Y., Hung W T. et al. Thromboelastogram fails to predict postoperative hemorrhage in cardiac patients. Ann Thorac Surg 1992 53 (3) 435-439
42. Davidson S J., McGrowder D, Roughton M, Kelleher A A. Can RoTEM thromboelastometry predict postoperative bleeding after cardiac surgery? J Cardiothorac Vasc Anesth 2008 22 (5) 655-661
43. Spiess B D., Tuman K J., McCarthy R J., DeLaria G A., Schillo R, Ivankovich A D. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 1987 3 (1) 25-30
44. Spiess B D., Gillies B S., Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995 9 (2) 168-173
45. Welsby I J., Jiao K, Ortel T L. et al. The kaolin-activated Thrombelastograph predicts bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 2006 20 (4) 531-535
46. Plotkin A J., Wade C E., Jenkins D H. et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma 2008 64 (2, Suppl) S64-S68
47. Johansson P I., Swiatek F, Jørgensen L, Jensen L P., Secher N H. Intraoperative platelet and plasma improves survival in patients operated for a rAAA: a follow-up evaluation. Eur J Vasc Endovasc Surg 2008 36 (4) 397-400
48. Carroll R C., Craft R M., Langdon R J. et al. Early evaluation of acute traumatic coagulopathy by thrombelastography. Transl Res 2009 154 (1) 34-39
49. Beilin Y, Arnold I, Hossain S. Evaluation of the platelet function analyzer (PFA-100) vs. The thromboelastogram (TEG) in the parturient. Int J Obstet Anesth 2006 15 (1) 7-12
50. Lombard F W., Welsby I J., Alexander M J., Borel C O. Thromboelastography detects inadequate response to abciximab therapy during stent-assisted cerebral aneurysm coil embolization complicated by stroke. Neurocrit Care 2006 4 (1) 32-34
51. Hobson A R., Agarwala R A., Swallow R A., Dawkins K D., Curzen N P. Thrombelastography: current clinical applications and its potential role in interventional cardiology. Platelets 2006 17 (8) 509-518
52. Coakley M, Reddy K, Mackie I, Mallett S. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006 20 (4) 548-553
53. Nielsen V G. A comparison of the Thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007 18 (3) 247-252
54. 5). ISBT Sci Series 2007 2 159-167
55. Cammerer U, Dietrich W, Rampf T, Braun S L., Richter J A. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003 96 (1) 51-57
56. Choong C K., Gerrard C, Goldsmith K A., Dunningham H, Vuylsteke A. Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes. Eur J Cardiothorac Surg 2007 31 (5) 834-838
57. Craft R M., Chavez J J., Bresee S J., Wortham D C., Cohen E, Carroll R C. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004 143 (5) 301-309
58. Katori N, Szlam F, Levy J H., Tanaka K A. A novel method to assess platelet inhibition by eptifibatide with thrombelastograph. Anesth Analg 2004 99 (6) 1794-1799
59. Ren Y H., Yang T S., Wang Y et al. Evaluation of triple anti-platelet therapy by modified thrombelastography in patients with acute coronary syndrome. Chin Med J (Engl) 2008 121 (9) 850-852
60. Vila P M., Zafar M U., Badimon J J. Platelet reactivity and nonresponse to dual antiplatelet therapy: a review. Platelets 2009 20 (8) 531-538
61. Hobson A R., Qureshi Z, Banks P, Curzen N. Gender and responses to aspirin and clopidogrel: insights using short thrombelastography. Cardiovasc Ther 2009 27 (4) 246-252
62. Collyer T C., Gray D J., Sandhu R, Berridge J, Lyons G. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography Platelet Mapping. Br J Anaesth 2009 102 (4) 492-498
63. Priesman S. The risk of postoperative bleeding in patients receiving clopidogrel can be predicted using modified bed-side thromboelastography. EACTS Daily News 2009 October 20 14
64. Lang T, Johanning K, Metzler H et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009 108 (3) 751-758
65. Rahe-Meyer N, Solomon C, Winterhalter M et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009 138 (3) 694-702
66. Reinhöfer M, Brauer M, Franke U, Barz D, Marx G, Lösche W. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008 19 (3) 212-219
67. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009 22 (2) 267-274
68. Mittermayr M, Streif W, Haas T et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007 105 (4) 905-917
69. Horácek M, Cvachovec K. The effects of cardiopulmonary bypass with hollow fiber membrane oxygenator on blood clotting measured by thromboelastography. Physiol Res 2002 51 (2) 145-150
70. Paparella D, Brister S J., Buchanan M R. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004 30 (10) 1873-1881
71. Rogers M AM, Blumberg N, Saint S, Langa K M., Nallamothu B K. Hospital variation in transfusion and infection after cardiac surgery: a cohort study. BMC Med 2009 7 37
72. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 2006 16 (1) 31-39
73. Spalding G J., Hartrumpf M, Sierig T, Oesberg N, Kirschke C G., Albes J M. Cost reduction of perioperative coagulation management in cardiac surgery: value of bedside thrombelastography (ROTEM). Eur J Cardiothorac Surg 2007 31 (6) 1052-1057
74. Fenger-Eriksen C, Ingerslev J, Sørensen B. Fibrinogen concentratea potential universal hemostatic agent. Expert Opin Biol Ther 2009 9 (10) 1325-1333
75. Fenger-Eriksen C, Jensen T M., Kristensen B S. et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009 7 (5) 795-802
76. Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008 48 (10) 2152-2158
77. Bolliger D, Szlam F, Molinaro R J., Rahe-Meyer N, Levy J H., Tanaka K A. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009 102 (6) 793-799
78. Fenger-Eriksen C, Tønnesen E, Ingerslev J, Sørensen B. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids. Acta Anaesthesiol Scand 2009 53 (3) 332-338
79. Dempfle C E., Kälsch T, Elmas E et al. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots. Blood Coagul Fibrinolysis 2008 19 (8) 765-770
80. Huissoud C, Carrabin N, Audibert F et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009 116 (8) 1097-1102
81. Gonano C KS, Panzer O P., Kozek S A. et al. Accuracy of native and activated thromboelastography for assessment of plasma fibrinogen levels. Anesthesiology 1998 89 (3A) A912
82. Rahe-Meyer N, Pichlmaier M, Haverich A et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009 102 (6) 785-792
83. Jüttner B, Brock J, Weissig A et al. Dependence of platelet function on underlying liver disease in orthotopic liver transplantation. Thromb Res 2009 124 (4) 433-438
84. Warnaar N, Lisman T, Porte R J. The two tales of coagulation in liver transplantation. Curr Opin Organ Transplant 2008 13 (3) 298-303
85. Tripodi A, Primignani M, Chantarangkul V et al. The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters. Thromb Res 2009 124 (1) 132-136
86. Tripodi A, Primignani M, Chantarangkul V et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009 137 (6) 2105-2111
87. Lerner A B., Sundar E, Mahmood F, Sarge T, Hanto D W., Panzica P J. Four cases of cardiopulmonary thromboembolism during liver transplantation without the use of antifibrinolytic drugs. Anesth Analg 2005 101 (6) 1608-1612
88. O'Connor C J., Roozeboom D, Brown R, Tuman K J. Pulmonary thromboembolism during liver transplantation: possible association with antifibrinolytic drugs and novel treatment options. Anesth Analg 2000 91 (2) 296-299
89. Gologorsky E, De Wolf A M., Scott V, Aggarwal S, Dishart M, Kang Y. Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transpl 2001 7 (9) 783-789
90. Manji M, Isaac J L., Bion J. Survival from massive intraoperative pulmonary thromboembolism during orthotopic liver transplantation. Br J Anaesth 1998 80 (5) 685-687
91. Cerutti E, Stratta C, Romagnoli R et al. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl 2004 10 (2) 289-294
92. Brohi K. Diagnosis and management of coagulopathy after major trauma. Br J Surg 2009 96 (9) 963-964
93. Selby R, Geerts W, Ofosu F A. et al. Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolism. Thromb Res 2009 124 (3) 281-287
94. Johansson P I. Hemostatic strategies for minimizing mortality in surgery with major blood loss. Curr Opin Hematol 2009 16 (6) 509-514
95. Johansson P I., Bochsen L, Stensballe J, Secher N H. Transfusion packages for massively bleeding patients: the effect on clot formation and stability as evaluated by Thrombelastograph (TEG). Transfus Apheresis Sci 2008 39 (1) 3-8
96. Johansson P I., Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang 2009 96 (2) 111-118
97. White N J., Martin E J., Brophy D F., Ward K R. Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation. Resuscitation 2010 81 (1) 111-116
98. Velik-Salchner C, Streif W, Innerhofer P et al. Endotoxinemia-induced changes in coagulation as measured by rotation thrombelastometry technique and conventional laboratory tests: results of a pilot study on pigs. Blood Coagul Fibrinolysis 2009 20 (1) 41-46
99. Martini W Z., Cortez D S., Dubick M A., Park M S., Holcomb J B. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 2008 65 (3) 535-543
100. Park M S., Martini W Z., Dubick M A. et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009 67 (2) 266-275; discussion 275276
101. Van P Y., Cho S D., Underwood S J., Morris M S., Watters J M., Schreiber M A. Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. J Trauma 2009 66 (6) 1509-1515; discussion 15151517
102. Spiezia L, Marchioro P, Radu C et al. Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. Blood Coagul Fibrinolysis 2008 19 (5) 355-360
103. Akay O M., Ustuner Z, Canturk Z, Mutlu F S., Gulbas Z. Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Med Oncol 2009 26 (3) 358-364
104. Bochsen L, Rosengaard L B., Nielsen A B., Steinbrüchel D A., Johansson P I. Platelet hyperreactivity in response to on- and off-pump coronary artery bypass grafting. J Extra Corpor Technol 2009 41 (1) 15-19
105. Kashuk J L., Moore E E., Sabel A et al. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery 2009 146 (4) 764-772, discussion 772774
106. Gurbel P A., Bliden K P., Saucedo J F. et al. Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study. J Am Coll Cardiol 2009 53 (8) 648-657
107. Dai Y, Lee A, Critchley L A., White P F. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg 2009 108 (3) 734-742
108. Perez de Prado A, Cuellas C, Diego A et al. Influence of platelet reactivity and response to clopidogrel on myocardial damage following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome. Thromb Res 2009 124 (6) 678-682
109. Bliden K P., DiChiara J, Tantry U S., Bassi A K., Chaganti S K., Gurbel P A. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? J Am Coll Cardiol 2007 49 (6) 657-666